The feasibility of prescription dose escalation for nasopharyngeal carcinoma cancer using helical tomotherapy / 中华放射医学与防护杂志
Chinese Journal of Radiological Medicine and Protection
;
(12): 35-39, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-490352
ABSTRACT
Objective To study the feasibility of helical tomoterapy (HT) at prescription dose escalation for nasopharyngeal carcinoma (NPC).Methods Static-IMRT (sIMRT) and HT plans were designed for 10 nasopharyngeal carcinoma patients which were treated by sIMRT and HT treatment plan.Prescription dose was escalated for each plan until any organs at risk (OARs) reached the quantitative analysis of normal tissue effects within the clinical threshold.Dosimetric factors of target and OARs were analyzed for both sIMRT and HT plans.Results Compared with sIMRT plan, prescribed dose of HT plans increased 42.6% (t =6.373, P < 0.01), and the homogeneity index was also improved (t =-2.288, P<0.05);the conformity index decreased (P > 0.05).The limits of HT prescribed dose escalation were spinal cord (2 cases), optic nerve (5 cases) and brainstem (3 cases).The limits of sIMRT prescribed dose escalation were lens (1 case), spinal cord (1 case) and parotid (8 cases).Conclusions HT could improve prescription dose of nasopharyngeal carcinoma while keeping the OARs safe.Compared with sIMRT, HT technology might be used at high dose NPC radiotherapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Radiological Medicine and Protection
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS